» Authors » Bhagwant Rai Mittal

Bhagwant Rai Mittal

Explore the profile of Bhagwant Rai Mittal including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 469
Citations 1658
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Aggarwal P, Anwariya A, Kaur K, Satapathy S, Sood A, Singh N, et al.
Clin Nucl Med . 2025 Mar; PMID: 40065397
Prostate-specific membrane antigen (PSMA) overexpression on prostate cancer cells finally led to the FDA approval of the therapeutic use of 177Lu-PSMA-617 in metastatic castrate-resistant prostate cancer. However, PSMA is also...
2.
Prashar S, Kumar A, Sood A, Mittal B
Indian J Nucl Med . 2025 Mar; 39(5):411-414. PMID: 40061510
Generally after the accreditation of the gamma camera, its unfailing optimal operation is guaranteed with established departmental preventive maintenance schedules. However, it is not easy to always religiously follow the...
3.
Aggarwal P, Krishnaraju V, Sood A, Mathur Y, Bhattacharya A, Mittal B
Indian J Nucl Med . 2025 Mar; 39(5):399-405. PMID: 40061500
Differentiated thyroid carcinoma (DTC) metastasizing to the adrenal glands is very infrequent. We present three cases of DTC with adrenal metastasis in their follow-up, in which two were from follicular...
4.
Aggarwal P, Kaur G, Bhadada S, Kumar R, Pandey S, Sood A, et al.
Clin Nucl Med . 2025 Feb; PMID: 40016943
Multiple endocrine neoplasia (MEN) 1 syndrome may present with either of any or all neuroendocrine tumors (NETs), parathyroid and pituitary adenoma. There is a paucity of data on the intronic...
5.
Gunasekaran V, Subrhamanian A, Ambalavanan N, Singh H, Kumar R, Mittal B, et al.
Clin Nucl Med . 2025 Jan; PMID: 39848221
Breast adenosis is a benign glandular proliferative disorder. Due to its imaging similarities with other malignant breast lesions, differentiating adenosis from other invasive carcinomas of the breast poses a diagnostic...
6.
Kumar S, Sood A, Kumar R, Pandey S, Shukla J, Mittal B, et al.
Cancer Biother Radiopharm . 2025 Jan; PMID: 39804177
Integrin antagonist complex (IAC), a novel αvβ3 integrin antagonist peptidomimetic, has emerged as a promising agent for molecular imaging of tumor angiogenesis. This study evaluates the biodistribution and clinical efficacy...
7.
Singh H, Mittal B, Mehrotra S, Bhasin D
Indian J Nucl Med . 2025 Jan; 39(4):327-328. PMID: 39790823
Adenosine is extensively utilized in myocardial stress perfusion imaging for the detection and risk stratification of coronary artery disease. It has a well-established safety profile. The majority of the undesirable...
8.
Satapathy S, Aggarwal P, Sood A, Chandekar K, Das C, Gupta R, et al.
J Nucl Med . 2025 Jan; 66(2):238-244. PMID: 39778968
Lu-DOTATATE has emerged as a viable treatment strategy for advanced well-differentiated grade 1/2 gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Few retrospective studies have shown concomitant Lu-DOTATATE with radiosensitizing low-dose capecitabine to be...
9.
Mahdi R, Saraswat D, Aggarwal P, Sood A, Kumar M, Mittal B
Clin Nucl Med . 2025 Jan; PMID: 39774447
Prostate cancer frequently metastasizes to bones; however, the detection of metastases can be challenging in rare locations. We present the case of a 76-year-old man with metastatic castration-resistant prostate cancer...
10.
Mahdi R, Saraswat D, Aggarwal P, Sood A, Kumar M, Mittal B
Clin Nucl Med . 2025 Jan; 50(2):e118-e119. PMID: 39774166
Prostate cancer frequently metastasizes to bones; however, the detection of metastases can be challenging in rare locations. We present the case of a 76-year-old man with metastatic castration-resistant prostate cancer...